Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “B-cell Chronic Lymphocytic Leukemia CLL”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02242942
What this trial is testing

Comparison of the Treatments of Obinutuzumab + Venetoclax Versus Obinutuzumab + Chlorambucil in Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Lymphocytic Leukemia, Chronic
Hoffmann-La Roche 445
Testing effectiveness (Phase 2)Study completedNCT01497496
What this trial is testing

Ofatumumab/Methylprednisolone and Ofatumumab/Lenalidomide for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
H. Lee Moffitt Cancer Center and Research Institute 29
Not applicableStudy completedNCT00569842
What this trial is testing

Investigation of the Cylex® ImmuKnow® Assay

Who this might be right for
LeukemiaNon-Hodgkin's LymphomaChronic Lymphocytic Leukemia+6 more
Indiana University 45
Not applicableLooking for participantsNCT06357754
What this trial is testing

Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

Who this might be right for
Non-Hodgkin LymphomaChronic Lymphocytic LeukaemiaMultiple Myeloma
Bristol-Myers Squibb 50
Testing effectiveness (Phase 2)Study completedNCT02213913
What this trial is testing

Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisB-cell Chronic Lymphocytic LeukemiaContiguous Stage II Adult Diffuse Large Cell Lymphoma+69 more
University of Chicago 55
Testing effectiveness (Phase 2)Study completedNCT02061761
What this trial is testing

Evaluate the Safety, Tolerability, and Efficacy of Relatlimab in Relapsed or Refractory B-Cell Malignancies

Who this might be right for
Hematologic Neoplasms
Bristol-Myers Squibb 106
Large-scale testing (Phase 3)Ended earlyNCT01732913
What this trial is testing

Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas

Who this might be right for
Indolent Non-Hodgkin's Lymphomas
Gilead Sciences 295
Testing effectiveness (Phase 2)Ended earlyNCT00801060
What this trial is testing

Evaluation of Safety and Efficacy of Fludarabine, Cyclophosphamide, and Rituximab (FCR) +/- Lumiliximab in Subjects With Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia
Biogen 40
Testing effectiveness (Phase 2)Ended earlyNCT00946023
What this trial is testing

Optimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and Rituximab

Who this might be right for
LymphomaB-cell LymphomaNon Hodgkin Lymphoma+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 135
Large-scale testing (Phase 3)Ended earlyNCT00089141
What this trial is testing

Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)

Who this might be right for
Cancer
Martin, Paul 151
Not applicableStudy completedNCT05260203
What this trial is testing

MargheRITA (Remote Intelligence for Therapeutic Adherence)

Who this might be right for
Multiple MyelomaSolitary PlasmacytomaAmyloidosis+11 more
Advice Pharma Group srl 124
Testing effectiveness (Phase 2)Study completedNCT00006373
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma

Who this might be right for
Lymphoma
H. Lee Moffitt Cancer Center and Research Institute 27
Testing effectiveness (Phase 2)Study completedNCT00002673
What this trial is testing

Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 30
Not applicableLooking for participantsNCT06475469
What this trial is testing

Description of the Immune Deficiency in Patients With Untreated Chronic Lymphocytic Leukemia and Search for Predictive Factors of Infectious Risk

Who this might be right for
Chronic Lymphocytic Leukemia
CHU de Reims 75
Large-scale testing (Phase 3)Looking for participantsNCT04269902
What this trial is testing

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
National Cancer Institute (NCI) 247
Early research (Phase 1)UnknownNCT03823365
What this trial is testing

Blinatumomab Expanded T-cells (BET) in Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic Leukemia

Who this might be right for
Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic Leukemia
A.O. Ospedale Papa Giovanni XXIII 19
Very early researchStudy completedNCT03771157
What this trial is testing

Serologic Response to SHINGRIX Vaccine in Patients With CLL and WM Treated With BTK Inhibitors

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Waldenstrom Macroglobulinemia (WM)
University of Rochester 33
Early research (Phase 1)Looking for participantsNCT04892277
What this trial is testing

CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies

Who this might be right for
Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Small Lymphocytic Lymphoma+5 more
Mayo Clinic 25
Testing effectiveness (Phase 2)Study completedNCT00283101
What this trial is testing

A Safety Study in Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia, Lymphocytic, Chronic
Seagen Inc. 12
Not applicableStudy completedNCT00577798
What this trial is testing

Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin

Who this might be right for
Cardiac ToxicityChemotherapeutic Agent ToxicityLymphoma
University of Nebraska 10
Next Page